The DOI matches its Crossref record.
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Abstract
Interleukin-6 (IL-6) is a multifunctional cytokine that regulates various aspects of the immune response, acute-phase reaction and haematopoiesis (for reviews see refs 1, 2). In vitro, leukaemia inhibitory factor, oncostatin M, ciliary neurotrophic factor and interleukin-11 display overlapping activities with IL-6. This functional redundancy may be explained by the interactions of specific binding receptors with a common signal-transducing receptor (gp130) (for reviews see refs 3, 4). To elucidate the unique function of IL-6 in vivo, we have disrupted the IL-6 gene by homologous recombination. IL-6-deficient mice develop normally. They fail to control efficiently vaccinia virus and infection with Listeria monocytogenes, a facultative intracellular bacterium. The T-cell-dependent antibody response against vesicular stomatitis virus is impaired. Further, the inflammatory acute-phase response after tissue damage or infection is severely compromised, whereas it is only moderately affected after challenge with lipopolysaccharide. We conclude that IL-6 production induced by injury or infection is an important in vivo SOS signal which coordinates activities of liver cells, macrophages and lymphocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, a certain amount of IL-6 is required for efficient immune defense (Kopf et al., 1994) and liver regeneration (Cressman et al., 1996; Sakamoto et al., 1999; Zimmers et al., 2003).”
From Model Based Targeting of IL-6-Induced Inflammatory Responses in Cultured Primary Hepatocytes to Improve Application of the JAK Inhibitor Ruxolitinib (2017) · cites this paper as Kopf et al., 1994
In the citing paper
“IL-6 is a critical inducer of the acute phase (AP) response in the liver, 11”
From Interleukin 6 Is Important for Survival After Partial Hepatectomy in Mice (2003) · cites this paper as [11]
In the citing paper
“IL-6 transgenic mice show severe plasmacytosis with hypergammaglobulinemia (147), while IL-6-deficient mice are defective in immunoglobulin production (148, 149).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [148]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 30
- Van-Snick, J. A. Rev. Immun. 8, 253–278 (1990). · DOI · Paper page
- Kishimoto, T. Blood 74, 1–10 (1989). · DOI
- Kishimoto, T., Akira, S. & Taga, T. Science 258, 593–597 (1992). · DOI · Paper page
- Stahl, N. & Yancopolous, G. D. Cell 74, 587–590 (1993). · DOI
- Rothstein, J. L. et al. Genes Dev. 6, 1190–1201 (1992). · DOI
- Lotz, M. et al. J. exp. Med. 167, 1253–1258 (1988). · DOI
- Uyttenhove, C., Coulie, P. G. & Van, S. J. J. exp. Med. 167, 1417–1427 (1988). · DOI
- Gupta, S. L., Hengartner, H. & Zinkernagel, R. Proc. natn. Acad. Sci. U.S.A. 82, 2604–2608 (1986). · DOI
- Suematsu, S. et al. Proc. natn. Acad. Sci. U.S.A. 86, 7547–7551 (1989). · DOI · Paper page
- Leist, T. P., Kohler, M. & Zinkernagel, R. M. Scand. J. Immun. 30, 679–686 (1989). · DOI
- Doherty, P. C., Allan, W. & Eichelberger, M. A. Rev. Immun. 10, 123–151 (1992). · DOI
- Spriggs, M. K. et al. Proc. natn. Acad. Sci. U.S.A. 89, 6070–6074 (1992). · DOI
- Huang, S. et al. Science 259, 1742–1745 (1993). · DOI
- Ramsay, A. J., Ruby, J. & Ramshaw, I. A. Immun. Today 14, 155–157 (1993). · DOI
- Kaufmann, S. A. Rev. Immun. 11, 129–163 (1993). · DOI
- Liew, F. Y. & Cox, F. E. G. Immunoparasit. Today A17–A21 (1991). · DOI
- Beckerman, K. P. et al. J. Immun. 150, 888–895 (1993). · DOI
- Gregory, S. H., Wing, E. J., Hoffman, R. A. & Simmons, R. L. J. Immun. 150, 2901–2909 (1993). · DOI
- North, R. J. J. Immun. 121, 806–810 (1978). · DOI
- Dalton, D. K. et al. Science 259, 1739–1742 (1993). · DOI
- Pfeffer, K. et al. Cell 73, 457–467 (1993). · DOI · Paper page
- Rothe, J. et al. Nature 364, 798–802 (1993). · DOI
- Havel, E. A., Moldawer, L. L., Helfgott, D., Kilian, P. L. & Sehgal, P. B. J. Immun. 148, 1486–1492 (1992). · DOI
- Koj, A. in Injury and Infection (eds Gordon, A. H. & Koj, A.) 145–160 (Elsevier, Amsterdam, 1985).
- Van Snick, J. et al. Proc. natn. Acad. Sci. U.S.A. 83, 9679–9683 (1986). · DOI
- Binder, D. & Kundig, T. M. J. Immun. 146, 4301–4307 (1991). · DOI
- Blanden, R. V. & Langmann, R. E. Scand. J. Immun. 1, 379–391 (1972). · DOI
- Ding, A. H., Nathan, C. F. & Stuehr, J. Immun. 141, 2407–2412 (1988). · DOI
- Baumann, H., Latimer, J. J. & Glibetic, M. D. Arch. Biochem. Biophys. 246, 488–493 (1986). · DOI
- Baumann, H. Meth. Enzym. 163, 566–594 (1988). · DOI
Cited by
Sorted by citations
Items 501–600 of 1,005
Interleukin-6 is a Marker of Inflammation with No Direct Role in Inflammasome-Mediated Mouse Models
McGeough, M. D., Peña, C., Mueller, J., Pociask, D., Broderick, L., Hoffman, H., & Brydges, S. (2012) · Journal of Immunology · doi:10.4049/jimmunol.1101737 · Cited by 93
Kiguchi, N., Maeda, T., Kobayashi, Y., Kondo, T., Ozaki, M., & Kishioka, S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.008 · Cited by 93
Purtha, W. E., Chachu, K. A., Virgin, H. W., & Diamond, M. (2008) · Journal of Virology · doi:10.1128/jvi.01646-08 · Cited by 84
“The following mice were purchased commercially: IFN- / (15), IL-6 / (27), and RAG T- and B-cell-deficient mice (35),”
Loppnow, H., Werdan, K., & Buerke, M. (2008) · Innate Immunity · doi:10.1177/1753425908091246 · Cited by 83
Kondo, S. (1999) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/sj.jidsp.5640205 · Cited by 101
Linkage of pycnodysostosis to chromosome 1q21 by homozygosity mapping
Gelb, B., Edelson, J. G., & Desnick, R. (1995) · Nature Genetics · doi:10.1038/ng0695-235 · Cited by 93
Okiyama, N., Sugihara, T., Iwakura, Y., Yokozeki, H., Miyasaka, N., & Kohsaka, H. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24689 · Cited by 99
Myskiw, C., Arsenio, J., van Bruggen, R., Deschambault, Y., & Cao, J. (2009) · Journal of Virology · doi:10.1128/jvi.02570-08 · Cited by 77
“For example, IL-6-deficient mice display a defective cytotoxic T-cell response against vaccinia virus and support 1,000-fold-greater viral replication in the lungs (25).”
BackgroundTanaka, T., Kanda, T., McManus, B. M., Kanai, H., Akiyama, H., Sekiguchi, K., Yokoyama, T., & Kurabayashi, M. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1428 · Cited by 92
Abbasifard, M., & Khorramdelazad, H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118097 · Cited by 100
“The findings of the mentioned studies also revealed that IL-6 could be critical for the survival of IL-6-deficient mice and virus clearance through participating in the modulation of T and B lymphocyte-associated responses, quenching inflammation, stimulating lung tissue repair, macrophage infiltration, and phagocytos…”
BackgroundCytokines and Soluble Receptors in Breast Milk as Enhancers of Oral Tolerance Development
Dawod, B., & Marshall, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00016 · Cited by 91
Neutrophil Migration Under Normal and Sepsis Conditions
Lerman, Y. V., & Kim, M. (2015) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x15666150108113236 · Cited by 116
“Indeed, IL-6, GM-CSF, and IL-3 single knock-out mice showed normal granulopoiesis [23-25], Lerman and Kim Page 2”
BackgroundBienz, M., Dai, W.-J., Welle, M., Gottstein, B., & Müller, N. (2003) · Infection and Immunity · doi:10.1128/iai.71.3.1569-1573.2003 · Cited by 91
“, Füllingsdorf, Switzerland) and interleukin-6 (IL-6)-deficient transgenic 129Sv C57BL/6 mice (10) backcrossed onto the C57BL/6 background for seven generations (kindly provided by M.”
BackgroundComplement-Dependent Acute-Phase Expression of C-Reactive Protein and Serum Amyloid P-Component1
Szalai, A., van Ginkel, F. V., Wang, Y., Mcghee, J., & Volanakis, J. (2000) · Journal of Immunology · doi:10.4049/jimmunol.165.2.1030 · Cited by 91
Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis
Goff, B. L., Blanchard, F., Berthelot, J., Heymann, D., & Maugars, Y. (2010) · Joint Bone Spine · doi:10.1016/j.jbspin.2010.03.002 · Cited by 91
Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice 1
van Enckevort, F. H. J., Netea, M. G., Hermus, A. R. M. M., Sweep, F. C. G. J., Meis, J. F. G. M., van der Meer, J. W. M., & Kullberg, B. J. (1999) · Medical Mycology · doi:10.1046/j.1365-280x.1999.00247.x · Cited by 86
Murine models of brain aging and age-related neurodegenerative diseases
Jucker, M., & Ingram, D. K. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(96)02243-7 · Cited by 93
Marsh, C. B., & Wewers, M. D. (1996) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70308-7 · Cited by 84
Li, X., Zhou, Z.-Y., Zhang, Y.-Y., & Yang, H.-L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154677 · Cited by 89
“In IL-6 knock-out mice, there are microstructure abnormalities in cortical bones and delayed fracture healing were observed [33, 34], in spite of the grossly normal phenotype [35, 36].”
BackgroundTanaka, T., Yamamoto, Y., Muromoto, R., Ikeda, O., Sekine, Y., Grusby, M. J., Kaisho, T., & Matsuda, T. (2011) · Science Signaling · doi:10.1126/scisignal.2001637 · Cited by 93
Reduced stress- and cold-induced increase in energy expenditure in interleukin-6-deficient mice
Asterholm, I. W., Edgley, A. J., Berndtsson, A., Fäldt, J., Bergström, G. M. L., Wallenius, V., & Jansson, J. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00514.2005 · Cited by 88
“(22) and have been bred onto a C57BL/6 background [as described by Wallenius (50)] to reduce genetic heterogeneity.”
BackgroundCampbell, S. J., Hughes, P., Iredale, J. P., Wilcockson, D. C., Waters, S., Docagne, F., Perry, V. H., & Anthony, D. C. (2003) · The FASEB Journal · doi:10.1096/fj.02-0757fje · Cited by 134
DONOR CYTOKINE GENOTYPE INFLUENCES THE DEVELOPMENT OF ACUTE REJECTION AFTER RENAL TRANSPLANTATION
Marshall, S. E., McLaren, A., McKinney, E. F., Bird, T. G., Haldar, N. A., Bunce, M., Morris, P. J., & Welsh, K. I. (2001) · Transplantation · doi:10.1097/00007890-200102150-00022 · Cited by 78
“IL-6 is an integral mediator of the acute phase response, and modulates both local and systemic immunity (28, 29).”
BackgroundTaga, T. (1997) · Annals of Medicine · doi:10.3109/07853899708998744 · Cited by 75
IL-21 Restricts Virus-driven Treg Cell Expansion in Chronic LCMV Infection
Schmitz, I., Schneider, C., Fröhlich, A., Frebel, H., Christ, D., Leonard, W., Sparwasser, T., Oxenius, A., Freigang, S., & Kopf, M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003362 · Cited by 88
“C57BL/6 WT and IL-6 mice [71] were from Charles River Inc.”
MethodSelf-citationInterleukin-6, its role in fibrosing conditions
O’Reilly, S., Ciechomska, M., Cant, R., Hügle, T., & van Laar, J. M. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.04.003 · Cited by 85
“6 KO mice do have an impaired immune response and an impaired acute phase response indicating the importance of IL-6 in mounting an effective immune response [16].”
BackgroundRegulated expression of gp130 and IL-6 receptor alpha chain in T cell maturation and activation.
Betz, U. (1998) · International Immunology · doi:10.1093/intimm/10.8.1175 · Cited by 70
“Transmitting editor: A. Radbruch Received 7 April 1998, accepted 28 April 1998 cell activity ( 6 ) and T cell-dependent antibody responses (6,7) are impaired, and infections with various pathogens cannot be controlled efficiently, suggesting that IL-6-mediated signals are involved in T cell function in vivo.”
BackgroundMethodInfluentialNavikas, V., Matusevicius, D., Söderström, M., Fredrikson, S., Kivisäkk, P., Ljungdahl, Å., Hojeberg, B., & Link, H. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00155-7 · Cited by 88
Acquired Muscle Weakness in the Surgical Intensive Care Unit
Farhan, H. N., Moreno‐Duarte, I., Latronico, N., ZAFONTE, R. D., & Eikermann, M. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000874 · Cited by 104
IL-6 Deficiency Attenuates Murine Diet-Induced Non-Alcoholic Steatohepatitis
Mas, E., Danjoux, M., Garcia, V., Carpentier, S., Ségui, B., & Levade, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007929 · Cited by 91
“IL-6 mice [18] were kindly provided by Dr.”
AN UPDATE ON THE PATHOPHYSIOLOGY OF RHINOVIRUS UPPER RESPIRATORY TRACT INFECTIONS
Cauwenberge, P. B. V., van Kempen, M., & Bachert, C. (1999) · Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology) · doi:10.7248/jjrhi1982.38.4_389 · Cited by 40
Role of cytokines in pulmonary antimicrobial host defense
Mehrad, B., & Standiford, T. (1999) · Immunologic research · doi:10.1007/bf02786504 · Cited by 87
Interleukin 6 and cognitive dysfunction
Trapero, I., & Cauli, O. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9551-2 · Cited by 98
“IL-6 plays a key role in the differentiation of B lymphocytes (Kopf et al. 1994) and protein breakdown in muscle (Goodman 1994).”
BackgroundSmith, K. A., & Maizels, R. M. (2013) · European Journal of Immunology · doi:10.1002/eji.201343746 · Cited by 89
Interleukin-6: From identification of the cytokine to development of targeted treatments
Assier, É., Boissier, M., & Dayer, J. (2010) · Joint Bone Spine · doi:10.1016/j.jbspin.2010.07.007 · Cited by 88
Makker, A., & Singh, M. (2006) · Medicinal Research Reviews · doi:10.1002/med.20061 · Cited by 84
Yeo, E. C. F., Brown, M. P., Gargett, T., & Ebert, L. M. (2021) · Cells · doi:10.3390/cells10030607 · Cited by 98
IL-6 and the acute phase response in murine atherosclerosis.
Song, L., & Schindler, C. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.06.018 · Cited by 85
Penkowa, M., Camats, J., Hadberg, H., Quintana, A., Rojas, S., Giralt, M., Molinero, A., Campbell, I., & Hidalgo, J. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10681 · Cited by 85
“However, this effect fits with the fact that IL-6 is a multifunctional cytokine, which has profound effects on the three major systems, the immune system, the hematopoietic system, and the nervous system (Heinrich et al., 1990; Hirano et al., 1990; Kopf et al., 1994; Hauser et al., 1997).”
BackgroundInterleukin-6 is required for parasite specific response and host resistance to Trypanosoma cruzi.
Gao, W.-D., & Pereira, M. A. (2002) · International Journal of Parasitology · doi:10.1016/s0020-7519(01)00322-8 · Cited by 85
Hepatocyte-specific mutation of both NF-κB RelA and STAT3 abrogates the acute phase response in mice
Quinton, L. J., Blahna, M. T., Jones, M. R., Allen, E., Ferrari, J. D., Hilliard, K. L., Zhang, X., Sabharwal, V., Algül, H., Akira, S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59408 · Cited by 84
“Hepatocytes are the predominant source of acute phase proteins in the blood (1), with induction dependent on IL-6 and the early response cytokines TNF-α and IL-1 (6–8), which activate STAT3 and NF-κ B in the liver (7–10).”
Shahin, T., Aschenbrenner, D., Cağdaş, D. N., Bal, S. K., Conde, C. D., Garncarz, W., Medgyesi, D., Schwerd, T., Karaatmaca, B., Çetinkaya, P. G., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.194233 · Cited by 96
Klyne, D. M., Barbe, M. F., van den Hoorn, W., & Hodges, P. W. (2018) · European Spine Journal · doi:10.1007/s00586-018-5490-7 · Cited by 101
Impaired hippocampus-dependent and -independent learning in IL-6 deficient mice.
Baier, P. C., May, U., Scheller, J., Rose-John, S., & Schiffelholz, T. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.01.013 · Cited by 84
Hao, Q., Wang, L., & Tang, H. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00504.2008 · Cited by 85
“IL-6 is a multifunctional cytokine that regulates immune response, inflammation, haematopoiesis, and acute phase response (16) and has been recognized as an important circulating inflammatory biomarker, predicting the risk of future cardiovascular events (2).”
BackgroundTargeting the development and effector functions of TH17 cells
Ghilardi, N., & Ouyang, W. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.016 · Cited by 92
Liang, Y., Christopher, K. B., Finn, P. W., Colson, Y. L., & Perkins, D. L. (2007) · Transplantation · doi:10.1097/01.tp.0000281384.24333.0b · Cited by 80
Johnson, P. M., Vogt, S., Burney, M., & Muglia, L. (2002) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.00388.2001 · Cited by 84
“However, inhibition of these proximal mediators of the inflammatory cascade would be expected to compromise survival in the setting of a live, replicating pathogen as suggested by the increased susceptibility of mice with genetic deficiency of TNF receptor 1 (31), IL-6 (14), and interferon- (6) to infection with bacte…”
BackgroundFlamme, A. C. L., & Pearce, E. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5829 · Cited by 68
The neutrophil: one cell on many missions or many cells with different agendas?
Christoffersson, G., & Phillipson, M. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2780-z · Cited by 83
“However, interleukin 6 (IL-6), GM-CSF and IL-3 have also been shown to stimulate granulopoiesis, but in a redundant manner (Kopf et al. 1994; Stanley et al. 1994; Nishinakamura et al. 1996).”
Hypoxia-Inducible Factor-2α Is an Essential Catabolic Regulator of Inflammatory Rheumatoid Arthritis
Ryu, J., Chae, C.-S., Kwak, J.-S., Oh, H., Shin, Y., Huh, Y. H., Lee, C., Park, Y.-W., Chun, C. H., Kim, Y., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001881 · Cited by 84
“Consistent with the inhibition of CIA by Il6 knockout [20,21], we also observed significantly greater inhibition of synovitis, pannus formation and invasion, cartilage destruction, and angiogenesis in inflamed synovium under CIA conditions in Il6 DBA/1J mice compared with WT littermates (Figure 9E and F).”
ResultScrepanti, I., Musiani, P., Bellavia, D., Cappelletti, M., Aiello, F. B., Maroder, M., Frati, L., Modesti, A., Gulino, A., & Poli, V. (1996) · Journal of Experimental Medicine · doi:10.1084/jem.184.4.1561 · Cited by 83
“We and other groups have recently generated IL-6 and C/EBP[3-deficient ( - / - ) mice by gene targeting (9-12).”
BackgroundMethodInterleukin-6 Protects Anterior Horn Neurons from Lethal Virus-Induced Injury
Pavelko, K., Howe, C., Drescher, K., Gamez, J., Johnson, A. J., Wei, T., Ransohoff, R., & Rodriguez, M. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-02-00481.2003 · Cited by 82
“One reaction was performed to detect either the neo cassette used to disrupt the IL-6 gene or the wild-type gene, and the other was performed to specifically detect the neo cassette (Kopf et al., 1994).”
BackgroundMethodNomura, T., Kawamura, I., Tsuchiya, K., Kohda, C., Baba, H., Ito, Y., Kimoto, T., Watanabe, I., & Mitsuyama, M. (2002) · Infection and Immunity · doi:10.1128/iai.70.3.1049-1055.2002 · Cited by 82
“LLO was shown to be capable of inducing the expression of various cytokine genes, including IL-1 , IL-6, IL-10, IL-12 p35, IL-12 p40, and TNF- genes, by CD11b cells.”
InfluentialAnguíta, J., Rincón, M., Samanta, S., Barthold, S. W., Flavell, R. A., & Fikrig, E. (1998) · The Journal of Infectious Diseases · doi:10.1086/314448 · Cited by 64
“body responses against vesicular stomatitis virus [8, 9], and”
BackgroundHaziot, A., Lin, X. Y., Zhang, F., & Goyert, S. (1998) · Journal of Immunology · doi:10.4049/jimmunol.160.6.2570 · Cited by 82
Targeting the mouse genome: a compendium of knockouts (part II)
Brandon, E. P., Idzerda, R. L., & McKnight, G. S. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00152-7 · Cited by 97
Libert, C., Takahashi, N., Cauwels, A., Brouckaert, P., Bluethmann, H., & Fiers, W. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240945 · Cited by 82
Self-citationBenrick, A., Schéle, E., Pinnock, S. B., Asterholm, I. W., Dickson, S. L., Karlsson-Lindahl, L., & Jansson, J. (2009) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2009.01879.x · Cited by 85
Kakeda, S., Watanabe, K., Katsuki, A., Sugimoto, K., Igata, N., Ueda, I., Igata, R., Abe, O., Yoshimura, R., & Korogi, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-28300-5 · Cited by 82
TRAIL/Apo-2 Ligand Induces Primary Plasma Cell Apoptosis
Ursini‐Siegel, J., Zhang, W., Altmeyer, A., Hatada, E. N., Do, R. K. G., Yagita∥, H., & Chen‐Kiang, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5505 · Cited by 71
“IgA responses are defective in the absence of IL-6 (20, 21).”
BackgroundParathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor.
Mitnick, M., Grey, A., Masiukiewicz, U., Bartkiewicz, M., Rios-Velez, L., Friedman, S., Xu, L.-M., Horowitz, M., & Insogna, K. (2001) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.3.e405 · Cited by 80
“IL-6 knockout mice exhibit impaired synthesis of acute-phase proteins (25), whereas hepatic overexpression of IL-6 in mice leads to exaggerated production of acute-phase proteins, an effect that is augmented by coexpression of the IL-6sR (35).”
BackgroundShared Cytokine Signaling Receptors: Structural Insights from the Gp130 System
Boulanger, M. J., & García, K. C. (2004) · Advances in protein chemistry · doi:10.1016/s0065-3233(04)68004-1 · Cited by 91
Storer, M. A., Gallagher, D., Fatt, M. P., Simonetta, J. V., Kaplan, D. R., & Miller, F. D. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.03.008 · Cited by 83
Interleukin 6, but Not T Helper 2 Cytokines, Promotes Lung Carcinogenesis
Ochoa, C. E., Mirabolfathinejad, S. G., Ruiz, V. A., Evans, S. E., Gagea, M., Evans, C. M., Dickey, B. F., & Moghaddam, S. J. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0180 · Cited by 81
“CC-LR/IL6KO mice were generated by crossing CC-LR mice to a previously generated mouse with a targeted mutation in exon 2 of the IL-6 gene (IL-6 KO mouse) (29).”
Rodriguez, M. D. C., Bernad, A., & Aracil, M. (2004) · Blood · doi:10.1182/blood-2003-10-3438 · Cited by 79
Evans, J., & Salamonsen, L. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.113.108175 · Cited by 79
“IL-6 Role in acute inflammation [59] Elevated in glandular epithelium and stroma in late secretory phase [60] CCL2 Localized to endometrial stroma [61] Recruits monocytes, macrophages, and dendritic cells into tissues [62] Regulates expression and activity of MT1MMP and MMP1 [63, 64] CXCL10 Activates CXCR3 on NK cells…”
BackgroundAcute Phase Proteins and Transformed Cells
Mackiewicz, A. A. (1997) · International review of cytology · doi:10.1016/s0074-7696(08)61623-x · Cited by 71
Lyons, R. E., Anthony, J. P., Ferguson, D. J. P., Byrne, N., Alexander, J., Roberts, F., & Roberts, C. W. (2001) · Infection and Immunity · doi:10.1128/iai.69.4.2589-2595.2001 · Cited by 79
“Female mice of the 129/SVJ strain (WT) and IL-6 mice of the same genetic background, as previously described (17), were”
BackgroundResultInfluentialGenovese, M. C., Kremer, J. M., van Vollenhoven, R., Alten, R., Scali, J. J., Kelman, A., Dimonaco, S., & Brockwell, L. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40176 · Cited by 86
Lang, R. (2005) · Immunobiology · doi:10.1016/j.imbio.2005.05.001 · Cited by 69
Poudrier, J., Weng, X., Kay, D., Paré, G., Calvo, E., Hanna, Z., Kosco-Vilbois, M., & Jolicoeur, P. (2001) · Immunity · doi:10.1016/s1074-7613(01)00177-7 · Cited by 78
de Hooge, A. D., van de Loo, F. V. D., Arntz, O., & van den Berg, W. (2000) · American Journal of Pathology · doi:10.1016/s0002-9440(10)64846-8 · Cited by 78
Moshyedi, A. K., Josephs, M. D., Abdalla, E. K., MacKay, S. L. D., Edwards, C. K., Copeland, E. M., & Moldawer, L. L. (1998) · Infection and Immunity · doi:10.1128/iai.66.4.1800-1802.1998 · Cited by 78
“If leptin is not involved or contributes only modestly to anorexia in this model, what mediators are contributory? In previous studies with turpentine-induced myositis, we and others have shown that endogenous production of IL-6 contributes significantly to the anorexia and loss of body weight that occur (4, 7).”
BackgroundMasiá, M., Fernández‐González, M., Padilla, S., Ortega, P., García, J. A., Agulló, V., García‐Abellán, J., Telenti, G., Guillén, L., & Gutiérrez, F. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102999 · Cited by 74
“In experimental models, IL-6 de fi ciency was associated with increased susceptibility to certain viral infections, which was attributed to impaired activity of cytotoxic T-cells, and the T-helper-dependent virus neutralizing IgG response [14,16].”
Goldman, J. L., Sammani, S., Kempf, C., Saadat, L., Letsiou, E., Wang, T., Moreno‐Vinasco, L., Rizzo, A., Fortman, J., & Garcia, J. G. N. (2014) · Pulmonary Circulation · doi:10.1086/675991 · Cited by 77
Interleukin-6 Trans-Signaling and Colonic Cancer Associated with Inflammatory Bowel Disease
Chalaris, A., Schmidt‐Arras, D., Yamamoto, K., & Rose‐John, S. (2012) · Digestive Diseases · doi:10.1159/000341698 · Cited by 33
Endogenous and Exogenous IL-6 Inhibit Aeroallergen-Induced Th2 Inflammation
Wang, J., Homer, R., Chen, Q., & Elias, J. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.4051 · Cited by 114
“The pro-inflammatory effects include the essential role of IL-6 in IgA production (17), turpentine-induced tissue inflammation (18), Lyme arthritis (19), tumor infiltration (20), Ag-induced arthritis (21), carrageenan-induced pleural inflammation (11), and the control and/or irradication of infections caused byMycobac…”
Interleukins 6 and 8 as Mediators of Acute Phase Response in Acute Myocardial Infarction
Pannitteri, G., Marino, B., Campa, P. P., Martucci, R., Testa, U., & Peschle, C. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00434-7 · Cited by 68
Leptin stimulates fetal and adult erythroid and myeloid development.
Mikhail, A., Beck, E. X., Shafer, A., Barut, B., Gbur, J. S., Zupancic, T., Schweitzer, A., Cioffi, J., Lacaud, G., Ouyang, B., et al. (1997) · Blood · doi:10.1182/blood.v89.5.1507.1507_1507_1512 · Cited by 77
Wang, J., Asensio, V. C., & Campbell, I. L. (2002) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-09525-6_2 · Cited by 74
Biswas, P., Delfanti, F., Bernasconi, S., Mengozzi, M., Cota, M., Polentarutti, N., Mantovani, A., Lazzarin, A., Sozzani, S., & Poli, G. (1998) · Blood · doi:10.1182/blood.v91.1.258 · Cited by 238
Henkin, R. I., Schmidt, L., & Velicu, I. (2013) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2013.3392 · Cited by 79
Kida, H., Mucenski, M. L., Thitoff, A. R., Cras, T. D. L., Park, K.-S., Ikegami, M., Müller, W., & Whitsett, J. A. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071052 · Cited by 74
“Whereas GP130-STAT3 signaling regulates diverse aspects of acquired innate defense, for example, T-cell proliferation and B-cell differentiation, 11,46 GP130-STAT3 also regulates many airway epithelial cell processes, including surfactant homeostasis, cell survival, and apoptosis.”
BackgroundThe role of interleukin-6 in stress-induced hyperthermia and emotional behaviour in mice.
Butterweck, V., Prinz, S., & Schwaninger, M. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00059-7 · Cited by 76
Armario, A., Hernández, J., Bluethmann, H., & Hidalgo, J. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00199-4 · Cited by 78
Self-citationViral Interleukin-6: Role in Kaposi's Sarcoma-Associated Herpesvirus–Associated Malignancies
Sakakibara, S., & Tosato, G. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0043 · Cited by 78
IL-6 receptor expression and IL-6 effects change during osteoblast differentiation
Li, Y., Bäckesjö, C., Haldosén, L.-A., & Lindgren, U. (2008) · Cytokine · doi:10.1016/j.cyto.2008.05.007 · Cited by 75
Estrogen restores cellular immunity in injured male mice via suppression of interleukin‐6 production
Messingham, K., Heinrich, S. A., & Kovacs, E. J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.6.887 · Cited by 75
“Although IL-6 normally plays a key role in maintaining immunity [25, 26], abnormally high levels of this cytokine in sera and tissues of burn patients correlate with the severity of injury and subsequent morbidity and mortality, even in the absence of sepsis [18, 21, 27–29].”
BackgroundGainsford, T., Nandurkar, H., Metcalf, D., Robb, L., Begley, C., & Alexander, W. (2000) · Blood · doi:10.1182/blood.v95.2.528 · Cited by 75
Physiological significance of STAT proteins: investigations through gene disruption in vivo
Levy, D. E. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050395 · Cited by 81
Regulation of emergency granulopoiesis during infection
Paudel, S., Ghimire, L., Jin, L., Jeansonne, D. P., & Jeyaseelan, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.961601 · Cited by 94
“Frontiers in Immunology 07 (82), they displayed reduced neutrophilia and neutrophil response during Listeria and Candida infections (83, 84).”
BackgroundA model for cancer-suppressive inflammation
Haabeth, O. A. W., Bogen, B., & Corthay, A. (2012) · OncoImmunology · doi:10.4161/onci.21542 · Cited by 75
Microarray‐based understanding of normal and malignant plasma cells
Vos, J. D., Hose, D., Reme, T. X., Tarte, K., Moreaux, J., Mahtouk, K., Jourdan, M., Goldschmidt, H., Rossi, J., Cremer, F. W., et al. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00362.x · Cited by 65
“Mice lacking this gene are impaired in T-cell-dependent antibody response (30), and conversely, transgenic mice expressing IL6 under the control of the Em enhancer promoter trigger a fatal polyclonal plasmacytosis (31).”
BackgroundLeblanc, R. A., Pesnicak, L., Cabral, E. S., Godleski, M., & Straus, S. E. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8145-8151.1999 · Cited by 74
“The IL-6 KO mice have a deficient acute-phase inflammatory response to vaccinia virus, vesicular stomatitis virus, and Listeria monocytogenes (14).”
BackgroundMethodA Role for Interleukin-6 in Host Defense against Murine Chlamydia trachomatis Infection
Williams, D. M., Grubbs, B., Darville, T., Kelly, K., & Rank, R. (1998) · Infection and Immunity · doi:10.1128/iai.66.9.4564-4567.1998 · Cited by 74
“These defects make IL-6 mice more susceptible than controls to a variety of pathogens (6, 9, 16, 21).”
BackgroundMethodInfluentialMolecular mechanisms of drug metabolism in the critically ill.
Park, G. (1996) · British Journal of Anaesthesia · doi:10.1093/bja/77.1.32 · Cited by 74
Transplantation of keratinocytes in the treatment of wounds
Myers, S. R., Navsaria, H. A., SANDERS, R. W., Green, C. J., & Leigh, I. M. (1995) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80258-x · Cited by 70
Linehan, J. L., Dileepan, T., Kashem, S. W., Kaplan, D. H., Cleary, P. P., & Jenkins, M. K. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513532112 · Cited by 74
C/EBPα Is Critical for the Neonatal Acute-Phase Response to Inflammation
Burgess-Beusse, B. L., & Darlington, G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7269 · Cited by 67
“For example, mice deficient in IL-1b (18), IL-1 receptor type I (34), TNF (37), or IL-6 (19, 29) all demonstrate a relatively normal LPS response, providing evidence for significant redundancy of function in cytokine signaling.”
Background
Metadata
- Authors
- Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G.
- Affiliations
- University of Zurich (CH)
- Max Planck Society (DE)
- The University of Osaka (JP)
- F. Hoffmann-La Roche AG (CH)
- Roswell Park Comprehensive Cancer Center (US)
- Venue
- Nature
- Published
- 1994-03-24
- Volume
- 368
- Issue
- 6469
- Pages
- 339-342
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2067761476
- Cited by
- 1,768
- References
- 0
- Citations by year
- 2026: 20 · 2025: 33 · 2024: 23 · 2023: 36 · 2022: 44 · 2021: 58 · 2020: 43 · 2019: 52 · 2018: 46 · 2017: 60 · 2016: 57 · 2015: 44 · 2014: 48 · 2013: 56 · 2012: 64
- FWCI
- 28.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- interleukin-6, IL-6-deficient mice, gene disruption, acute phase response, immune response, vaccinia virus infection, Listeria monocytogenes, T cell-dependent antibody response, vesicular stomatitis virus, lipopolysaccharide, gp130, cytokine redundancy, inflammation, macrophages, liver
- MeSH terms
- Acute-Phase Reaction, Animals, B-Lymphocytes, Immunity, Listeriosis, Lymphoid Tissue, Mice, Inbred C57BL, RNA, Messenger, T-Lymphocytes, Vesicular stomatitis Indiana virus, Interleukin-6, Rhabdoviridae Infections, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review